Exploring the Potential of THR Integration in Harm Reduction

Nov.23.2022
Exploring the Potential of THR Integration in Harm Reduction
The 13th National Injury Reduction Conference held in Puerto Rico addressed harm reduction topics such as drug use, tobacco use, and racial justice.

Image source: Filter. The following article is written by Kevin Garcia, a harm reduction researcher at Filter.


The 13th National Injury Reduction Conference took place in mid-October in San Juan, Puerto Rico. Approximately 2,800 injury reduction experts from the United States and other countries attended the conference, which focused on topics such as preventing opioid abuse, drug testing, racial justice, and sex work.


I also joined a group focused on harm reduction in tobacco. Given the occasional differences between tobacco harm reduction and other forms of harm reduction work, it is crucial to have ongoing dialogue on how to keep them aligned. Including this issue in the group's discussions is significant.


Therefore, I took this opportunity to ask some of the attendees about their thoughts. Their answers reflected some obstacles to better understanding, their personal experiences with THR, and some truly encouraging interest in incorporating THR into their work.


Electronic cigarettes? Those things are too scary for you.


Unfortunately, after non-profit organizations and public health agencies in the United States launched a relentless campaign of misinformation about the use of e-cigarettes, some misunderstandings have persisted – even among those who are trying to reduce harm. "E-cigarettes? Those things are just too scary for you," said one anonymous participant who was smoking. Evidence shows that while using e-cigarettes is not completely risk-free, it is much less harmful than traditional cigarettes. For example, the Royal College of Physicians in the UK notes that the long-term harm from e-cigarettes is unlikely to exceed 5% of the harm caused by smoking. Other harm-reducing alternatives, such as oral snus and "heat not burn" tobacco products, are also available. Nathan Smiddy, a harm reduction educator with A New Path in California, is uncertain about some health issues despite using e-cigarettes himself. "I don't know if popcorn lung is a real thing. I've never researched it. To me, using e-cigarettes costs less than smoking and feels better." Smiddy's primary motivation for switching was economic, which is an inspiring fact for debates about e-cigarette and cigarette taxes. "To be honest, cigarettes are very expensive. I don't think I can afford them now. So I bought an e-cigarette and stuck with it. I started smoking/using e-cigarettes at 15 and I'm 30 now. I feel it's safer, but I have no evidence to prove it. My overall health and quality of life have simply improved from the switch. And I don't wake up coughing up phlegm." Harm reducers often speak candidly about their lack of knowledge about THR, which is a good starting point for discussion.


I have many customers who have switched to using e-cigarettes instead of smoking traditional cigarettes.


I don't fully understand its scientific validity, but I will speak candidly," said Gillian Garton, who serves as a medical case manager for the Red Project in Grand Rapids, Michigan, and emphasized that she is speaking only on her own behalf. "I do know that some people use vaping to reduce their cigarette consumption, or switch entirely to vaping because I know there have been some changes in health. I have many clients who have switched to vaping instead of smoking cigarettes.


In fact, she did the same. "I used to smoke a lot before, starting at around 15 years old. I have been trying to quit smoking for a long time, so I switched to using e-cigarettes mainly for my own health.


Garton acknowledges the recent trend of banning electronic cigarettes and the potential harmful consequences that may arise. "I am aware that there have been many legislative attempts to ban electronic cigarettes," she said. She pointed out that people's reaction may be: "I do not have the opportunity to use this type of electronic cigarette, so perhaps I have to buy tobacco, but I still crave an electronic cigarette.


When it comes to the ban, I didn't see a positive side, only a negative side," said Presto Crespo, a resident of the Bronx. "People will just go back to smoking. Or they'll make their own stuff; sometimes it might be safe, sometimes it might be harmful to the body.


During our group discussion, we debunked myths and discussed the necessity of integrating THR in a wider field. Following this, some attendees stated that they are now giving more consideration to these matters.


I hadn't given much thought to the issue before our group discussion," said Crespo. "I believe I may have succumbed to some misinformation about e-cigarettes, but as a general skeptic, I always thought that something seemed off and couldn't be entirely true. However, I do agree that it's the way big tobacco companies are getting the new generation addicted to their products," they continued. However, their perspective was challenged after seeing their roommate transition from smoking to using e-cigarettes. "It was helpful to see that he felt like he had better lung capacity and was no longer constantly coughing and spitting.


Despite this, when it comes to evidence, "I don't know if there is a reduction in harm when transitioning from cigarettes to e-cigarettes," Crespo said. "E-cigarettes are everywhere. But some people still believe that e-cigarettes can explode.


I know someone who cannot take any other medication because they are taking methadone, so cigarettes are their only option. When I suggested trying e-cigarettes to this person, they refused, fearing that they would explode in their face. This person is clearly misinformed and continues to consume these packaged cigarettes.


After this conversation, I gained a better understanding of why this falls completely under the category of reducing harm.


I do not regularly use drugs or smoke," said Dan Coello, the project director of NEXT Distro, a company that provides harm reduction supplies such as naloxone and syringes through online purchases and mail delivery. "Before attending the group discussion, my knowledge of harm reduction was almost nonexistent...I believed that many of the risks we dealt with in the harm reduction movement were simply a matter of overuse or overconsumption. After the lecture, I came to understand that this falls completely within the realm of harm reduction.


What are the prospects of including tobacco harm reduction (THR) as a means of minimizing the harm caused by drug addiction for those who are prohibited from using drugs? After all, in the US alone, smoking is responsible for almost 500,000 deaths each year – more than any other substance – and a high proportion of illegal drug users also smoke.


Yes, people haven't really noticed this, what I mean is that humans tend to focus very strictly on immediate benefits and risks, and we're not very good at long-term thinking. Therefore, I believe that theoretical ideas like, for example, a large number of people dying from lung cancer in the future, don't feel as immediate as the direct risk of overdosing on medication.


Garton agrees with this viewpoint: "What I want to say is that tobacco is not a top priority in the harm reduction movement. Additionally, the shame associated with smoking tobacco is not as great as the shame associated with using other substances. Focusing attention on issues with higher levels of stigma is out of touch. This is not to say that I believe harm reduction advocates do not care about THR, but rather that we have a bigger stigmatization problem when it comes to other substances.


I believe that THR needs to be taken more seriously within the human resources community," said Crespo. "We are very concerned about cases of overwork, where people become ill quickly. We are working hard to prevent these situations, but we also need to focus on the long-term well-being of our employees. I don't think this is being discussed enough.


Communicating with tobacco users is currently something we can pursue.


I don't think the actions being called for within the community have been fully realized yet, such as understanding what exactly we can do," Coello said. "One thing we can start with is connecting two different worlds, such as those who are passionate about reducing tobacco harm and those who advocate for harm reduction in general. Therefore, first and foremost, there needs to be solid communication and friendship. Then, although the legal status of drugs may differ, the overall values of harm reduction should be consistent. Everyone needs to have a shared understanding of what it is and what can be done to reduce harm.


We already know and understand how to communicate with people who use electronic cigarettes, and we can draw on that experience to communicate with people who use tobacco," he continued. "I am confident that many of our participants smoke or use e-cigarettes; we can leverage our ability to reach these individuals and offer safer alternatives to smoking or combustion-based tobacco use or methods of nicotine delivery.


Personally, I want to learn more and better understand THR, as well as how NEXT can specifically initiate such things," summarized Coello. "I am not sure if we have reached a stage where meaningful changes can be made, but I hope that NEXT can play a role in the future.


Statement:


The content of this article is compiled from third-party information and is intended for industry communication and learning purposes.


This article does not reflect the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of its content. The translation of this article is intended solely for industry exchange and research.


Due to limitations in the quality of the translation process, the translated article may not fully reflect the original text. Please refer to the original article for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions, 2FIRSTS is fully aligned with the Chinese government.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Product | PMI Launches Three IQOS ILUMA i BEYOND Limited Editions in Japan, Retaining REMIX Pricing and Retail Channel Structure
Product | PMI Launches Three IQOS ILUMA i BEYOND Limited Editions in Japan, Retaining REMIX Pricing and Retail Channel Structure
Philip Morris Japan (PMJ) began launching three IQOS ILUMA i BEYOND limited-edition heated tobacco devices in Japan on November 18, 2026, covering PRIME, the standard ILUMA i and ONE. Suggested retail prices are ¥11,980, ¥7,980 and ¥4,980, respectively, matching the REMIX limited-edition collection introduced in June. BEYOND features blue finishes, translucent components and differentiated surface materials while retaining the existing IQOS ILUMA i device architecture. As with REMIX, all three models are available through official and specialist retail channels, while the subsequent convenience store rollout covers only the standard ILUMA i and ONE versions. The two collections share the same pricing tiers and retail distribution structure, with their principal differences in exterior design.
product
Nov.20
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
South Korea's Synthetic Nicotine Tax Take Estimated at Just 1.3% of Forecast as Imports Plunge Nearly 97%
South Korea's Synthetic Nicotine Tax Take Estimated at Just 1.3% of Forecast as Imports Plunge Nearly 97%
After synthetic nicotine was placed under tobacco regulation on April 24, 2026, South Korea’s tax collections from synthetic-nicotine vaping products fell far short of government projections. The Chosun Ilbo reported on November 18 that Ministry of Health and Welfare data showed national health promotion charges on synthetic-nicotine liquid e-cigarettes totaled 765 million won from April 24 through September. Using statutory rates, the newspaper estimated combined major taxes and charges at about 2.622 billion won—on a monthly basis roughly 1.3% of an earlier forecast after temporary tax reductions. Customs data showed synthetic-nicotine imports dropped from about 1,467 metric tons in January–April to 45 metric tons in May–August, a nearly 97% decline. Imports of nicotine-analog and nicotine-free liquids totaled 151 metric tons in May–August, exceeding synthetic-nicotine imports in the same period, though both categories were also below January–April volumes.
Regulations
Nov.19
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Complete abstinence is not always the goal of addiction treatment under a harm-reduction approach, Japanese psychiatrist Tomohiro Shirasaka told 2Firsts in Manila. In the interview, he discussed patients' quality of life, Japan's shift towards heated tobacco products, and the challenges of quitting smoking for people with mental illness. Drawing on addiction treatment work in the Philippines, he advocated support rather than punishment and questioned whether fear-based health warnings effectively address the reasons people continue smoking.
Nov.10
Brad Rodu Says Declining Cigarette Smoking Is Key to Tobacco Harm Reduction | 2Firsts Interview
Brad Rodu Says Declining Cigarette Smoking Is Key to Tobacco Harm Reduction | 2Firsts Interview
After more than 30 years researching tobacco harm reduction, University of Louisville professor Brad Rodu says opposition to smoke-free alternatives still surprises him. In an exclusive 2Firsts interview in Manila, he argued that declining smoking rates represent progress even if nicotine use rises, discussed nicotine and cancer, and examined Sweden's snus experience and youth vaping. Rodu welcomed recent FDA decisions but criticized slow reviews and poor risk communication. He called a change in the WHO's stance potentially significant, while doubting it would happen soon.
Nov.20